News Archive
Pharmasset, Inc. today announces the initiation of a 28-day Phase 2a study with PSI-7977, a chirally pure isomer form of PSI-7851, a nucleotide analog polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV). The trial will evaluate various doses of PSI-7977 in combination with Pegasys (peginterferon alfa 2a) and Copegus (ribavirin) in patients with HCV genotype 1 who have not been treated previously.
Two innovative and highly successful models of care developed by nurses were the centerpiece of a briefing today on health care reform. The event, which brought together women's health leaders and health care experts, focused on the ways in which innovative health care models can help to improve efficiency, reduce costs and ensure quality care for patients and their families.
Pfizer today announced results from an exploratory analysis of the Intergroup Exemestane Study (IES) at a median follow-up of 91 months in estrogen-receptor positive (ER+) or estrogen-receptor unknown (ER-unknown) women that looked at breast cancer free survival (BCFS) and censored deaths that occurred prior to breast cancer relapse.
Conceptus, Inc., developer of the Essure procedure, the first proven non-incisional permanent birth control method available, today announced that the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom has updated its guidance on hysteroscopic sterilization to support the use of the Essure permanent birth control procedure.
Kaiser Health News staff writers Andrew Villegas and Phil Galewitz, writing in collaboration with USA Today, report on the status of health insurance assistance for the unemployed: "Jennifer Richards of Park Ridge, Ill., is angry that her family's monthly health insurance bill tripled in August to $1,250 after her husband lost his job and health benefits. But as bad as that is, what really upsets her is the inaction of Congress"
› Verified 5 days ago